Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R. A., & Schmiegel, W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 834

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793

Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man

Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670

Hamster preproglucagon contains the sequence of glucagon and two related peptides

Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats

Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597

Attenuated GLP-1 secretion in obesity: cause or consequence

Ranganath, L. R., Beety, J. M., Morgan, L. M., Wright, J. W., Howland, R., & Marks, V (1996) · Gut · doi:10.1136/gut.38.6.916 · Cited by 394

Leptin Signaling In the Brain

Reizes, O., Benoit, S. C., & Clegg, D. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_2

Gastrointestinal signals regulating appetite in humans

Oesch, S. (2005) · edoc (University of Basel) · doi:10.5451/unibas-003768417

Gut induced biomarkers of appetite and satiety

Meyer‐Gerspach, A. C. (2012) · edoc (University of Basel) · doi:10.5451/unibas-006055102

Methods in the treatment of obesity

López, J. A. F., Remesar, X., & Lamana, M. A. (2000) · Estudis Romànics (Institut d'Estudis Catalans) · doi:10.2436/cs.v0i0.272

Changes in gastrointestinal hormones, leptin, and satiety after gastric bypass surgery

Beckman, L. M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)

Islet Amyloid Polypeptide/GLP‐1/Exendin

Baggio, L. L., & Drucker, D. J. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0209

Glycaemic Response in Relation to Gastric Emptying and Satiety in Health and Disease

Hlebowicz, J. (2008) · Lund University Publications (Lund University)

Untersuchung der Effekte des GLP-1 Systems auf Komponenten des Metabolischen Syndrom in vivo

Piotrowski, K. (2013) · doi:10.5282/edoc.15458

Body Weight Regulation and Hypothalamic Neuropeptides

Prodam, F., Me, E., Riganti, F., Seardo, M. A., Lucatello, B. G., Maccario, M., Ghigo, E., & Broglio, F. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_27

Effects of palatable diets on appetite regulation, appetite peptides and neurogenesis.

Lindqvist, A. (2006) · Lund University Publications (Lund University)

The gut hormones and their roles in obesity and gastric restrictive surgery

Adrian, T. E., Denham, W., & Prystowsky, J. B. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200310000-00003

Hormones and Gastrointestinal Function

Prodam, F., Bellone, S., Savastio, S., Busti, A., Guidi, C., Monzani, A., & Bona, G. (2012) · Springer eBooks · doi:10.1007/978-88-470-1405-3_43

The Acute Effect of Exercise on Energy Intake in Overweight Women

Unick, J. L. (2009) · D-Scholarship@Pitt (University of Pittsburgh)

Regulation of food intake : a focus on ghrelin

Blom, W. A. M. (2005) · doi:10.18174/27836

Effects of fiber on satiety, food intake, glucose, insulin, and gut hormones in healthy human subjects

Willis, H. J. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)

Effect of a rapidly fermentable fiber on satiety, food intake, and tolerance in healthy human subjects.

Hess, J. R. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)

A porcine type 1 Diabetes Mellitus model, for non-invasive in vivo imaging of the glucagon-like peptide-1 receptor in the pancreas, using [68Ga]Ga-DO3A-VS-Cys40-conjugated synthetic exendin-4 in PET-CT

Andréasson, S. (2015) · Epsilon Archive for Student Projects (University of Southampton)

Gastric acid secretion and gut peptides: mechanisms involved in inflammatory response

Feldreich, T. (2010) · Figshare

DIGESTIVO Interaction sbetwee ngastri cemptyin gan dsatiety , withspecial referenc et oglucagon-lik epeptide-1

Hellström, P. M., & Näslund, E. B. (2001)

THE EFFECTS OF INTERMITTENT FASTING AND A HIGH PROTEIN DIET IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS

Bowen, M. J. (2015) · University Library - University of Saskatchewan (University of Saskatchewan)

Efeito do peptídeo-1 semelhante ao glucagon endógeno sobre a atividade do NHE3 em túbulo proximal renal

Farah, L. X. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-05102015-114814

ENTERO-OMENTECTOMIA ADAPTATIVA COMO TRATAMENTO AUXILIAR DO DIABETES MELLITUS TIPO 2

Milléo, F. Q. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

POUR LE DIPLÔME D'ÉTAT DE DOCTEUR EN MÉDECINE

Sabatier, P., Médecine, F. D., Clinique, M. S., & Bally, É. (2013)

Development of new incretin drugs: Promising therapies Development of new incretin drugs: Promising therapies Development of new incretin drugs: Promising therapies Development of new incretin drugs: Promising therapies Development of new incretin drugs: Promising therapies

Kaur, K. (2006)

DPP 4 (dipeptidylpeptidase-4) inhibitors: beyond glycemic control

Gothwal, S. (2013) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-033108185

Exenatide as a novel treatment for Parkinson's Disease

Avilés-Olmos, I. (2013) · UCL Discovery (University College London)

Efeito do peptídeo-1 semelhante ao glucagon endógeno sobre a atividade do NHE3 em túbulo proximal renal

Paulo, S., & Girardi, C. (2015)

Glucagon like peptide-1 (glp-1) in myocardial ischaemia-reperfusion injury.

Bose, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)

Potential therapies to limit obesity

Halford, J. C. G. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541643.012

Obesity: Treatment and Complications

Chaptini, L. A., & Peikin, S. R. (2016) · Wiley eBooks · doi:10.1002/9781118512104.ch62

Bioactive Peptides in Gut–Brain Signaling

Näslund, E. B., Grybäck, P., & Hellström, P. M. (2009) · CRC Press eBooks · doi:10.1201/9781420061161-c12

Brain-Based Drivers and Consequences of Hedonic Overeating

Burger, K. S., Kantak, P. A., & Sanders, A. J. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199330454.003.0006

Regulation of Macronutrient Preference-Component of Food Selection

Halford, J. C. G., & Blundell, J. E. (2005) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203564554.ch7

Abbreviated Title: Extra-Pancreatic Effects of GLP-1

Abu‐Hamdah, R., Rabiee, A., Meneilly, G. S., Shannon, R. P., & Elahi, D. (2009)

Central Functions of Glucagon-like Peptide-1: Roles in Energy Regulation and

McGrath, N., Glastras, S. J., HOCKING, S. L., Tjoeng, I., Krause, M., Fulcher, G. R., & McGrath, R. T. (2015)

β-Glucans and Post Prandial Satiety: The Role of Intestinal Hormones in Healthy VolunteersPreprint

Baldassano, S., Buscemi, S., Aiello, A., Accardi, G., Caruso, C., & Vasto, S. (2016) · Preprints.org · doi:10.20944/preprints201612.0120.v1

Gastric Bypass in Morbid Obesity : Postoperative Changes in Metabolic, Inflammatory and Gut Regulatory Peptides

Holdstock, C. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

The development of gut hormones as drugs for the treatment of obesity

Cuenco, J. (2014) · doi:10.25560/42780

O efeito da deleção do SOCS3 em células responsivas à leptina em diferentes condições experimentais.

Pedroso, J. A. B. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-16052017-142324

THE EFFECT OF BREAKFAST CONSUMPTION ON THE ACUTE RESPONSE OF PLASMA ACYLATED-GHRELIN AND GLUCAGON-LIKE PEPTIDE 1 CONCENTRATIONS IN ADULT WOMEN

Hritz, T. A. (2011) · D-Scholarship@Pitt (University of Pittsburgh)

The Effect of 6 Weeks Resistance Training and HITT on GLP-1 Gene Expression of Diabetic Rats

Kalhor, H., Peeri, M., Matinhomaee, H., & Izadi, M. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

The Pathophysiology of Appetite Control

Halford, J. C. G., & Blundell, J. E. (2004) · CRC Press eBooks · doi:10.1201/9780203508756-10

Testing novel fat replacers for weight control

Logan, C., Wallace, J. M. W., Robson, P. J., & Livingstone, M. B. E. (2006) · Elsevier eBooks · doi:10.1533/9781845691073.2.391

Glucagon‐Like Peptide‐1 Receptor Activators

Wagner, M., Evers, A., Bossart, M., & Konkar, A. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc268

Biopsychological investigation of satiety responsiveness and its implications for appetite control

Hollingworth, S. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

Development of protocols to identify high hunger and low satiety phenotypes

Elfarssi, H. M. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00370

Lipoproteins in the postprandial state: Studies on the metabolism of triglyceride-rich lipoproteins using multicompartmental models

Björnson, E. (2021) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Obesity: Treatment and Complications

Chaptini, L. A., & Peikin, S. R. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch115

Gut Peptides

Amber, V., & Bloom, S. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_2

The Pathophysiology of Appetite Control

Blundell, J. E., & Halford, J. C. G. (2004) · CRC Press eBooks · doi:10.1201/9780203508756.ch2

Hormones and Gastrointestinal Function of Newborns

Prodam, F., Bellone, S., Ricotti, R., Monzani, A., Genoni, G., Giglione, E., & Bona, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-29489-6_184

Gut Peptides

Vakilgilani, T., Zac‐Varghese, S., & Bloom, S. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_3

Neuroregulation of Appetite

Reizes, O., Benoit, S. C., & Clegg, D. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2311-3_1

Obesity

Murray, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00192-9

The entero-insular axis and metabolic syndrome

Sarkar, J., & Chakrabarti, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00047-5

The science behind the lifesum app: an intervention design analysis

Svanfeldt, S., Seth, C., Gners, M., & Blomqvist, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-97852-0

Regulation of Feeding Behavior by Glucagonlike Peptide 1 (GLP-1)

Vuguin, P. M., & Charron, M. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50136-7

Glucagon-like Peptides and Insulin Sensitivity

Holst, J. J., & Knop, F. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_13

Etude des potentiels satiétogène et antistress d’extraits de levure Saccharomyces cerevisiae

Catiau, L. (2010) · theses.fr (ABES) · doi:10.70675/a9fc74dfz9c01z4e59zaffaz7fe892a4b2ca

Neglected GLP-1 receptors in the eyes and nose: possible correlation with regulation of appetite

Saturnino, A., & Pozzilli, P. (2026) · Endocrine · doi:10.1007/s12020-026-04581-z

Modulation de la dépression synaptique à long terme dans le noyau du tractus solitaire par le statut nutritionnel

Khlaifia, A. (2015) · theses.fr (ABES) · doi:10.70675/48826ff3zef5bz49d0z8389z57ab7666f35b

Evidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome

Carmina, E., & Longo, R. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135165

From Food Structure to L-Cell Exposure: How Processing and Digestion Shape Endogenous GLP-1 Responses

Šantić, R., Kumrić, M., Kurir, T. T., Rušić, D., & Božić, J. (2026) · Molecules · doi:10.3390/molecules31193375

Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity

Elashi, A. A., Hedaya, L., Maggio, V., Naja, K., Rizzo, M., & Elrayess, M. A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1812193

The GLP-1 receptor agonist semaglutide reduces alcohol consumption and anxiety-like behaviors during withdrawal in Marchigian Sardinian alcohol-preferring rats

Palmisano, M., Mrizak, H., Gonzalez, A. E., Onge, C. M. S., Erikson, C. M., Cruz, B., Flores‐Bonilla, A., Vlkolinský, R., Sharlai, O., Benedict, J., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111240

True

Flint, A., Raben, A., Astrup, A. V., Ersbøll, A. K., & Holst, J. J. (2001) · International Journal of Obesity · doi:10.1038/sj/ijo/0801627

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

Flint, A., Raben, A., Ersbøll, A., Holst, J., & Astrup, A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801627 · Cited by 384

Rapid Publication Glucagon-like Peptide 1 Promotes Satiety and Suppresses Energy Intake in Humans

Invest, J. C., Flint, A., Raben, A., Astrup, A., & Holst, J. J. (2016)

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

Näslund, E. B., Gutniak, M., Skogar, S., Rössner, S., & Hellström, P. M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.525 · Cited by 304